| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 56.52B | 58.49B | 54.23B | 46.73B | 48.14B | 43.81B |
| Gross Profit | 21.62B | 22.10B | 20.29B | 16.27B | 17.38B | 16.59B |
| EBITDA | 16.82B | 14.10B | 15.57B | 12.25B | 13.55B | 13.04B |
| Net Income | 8.75B | 10.06B | 8.05B | 6.33B | 7.35B | 6.91B |
Balance Sheet | ||||||
| Total Assets | 80.15B | 89.29B | 82.78B | 77.94B | 74.90B | 70.07B |
| Cash, Cash Equivalents and Short-Term Investments | 15.68B | 14.73B | 17.98B | 20.91B | 20.91B | 20.11B |
| Total Debt | 3.40B | 2.32B | 3.88B | 5.10B | 2.94B | 4.29B |
| Total Liabilities | 14.83B | 16.63B | 17.05B | 18.01B | 17.25B | 17.61B |
| Stockholders Equity | 60.43B | 66.76B | 60.65B | 55.46B | 53.84B | 49.10B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.01B | 3.55B | 3.09B | 5.28B | 5.31B |
| Operating Cash Flow | 0.00 | 7.75B | 9.08B | 7.88B | 9.89B | 9.87B |
| Investing Cash Flow | 0.00 | -9.96B | -6.19B | -4.63B | -5.09B | -5.04B |
| Financing Cash Flow | 0.00 | -1.16B | -5.12B | -3.24B | -4.56B | -4.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥110.76B | 15.71 | ― | 4.64% | 3.11% | -37.18% | |
78 Outperform | ¥191.75B | 14.78 | ― | 3.39% | 7.85% | 24.91% | |
77 Outperform | ¥86.08B | 8.96 | ― | 3.82% | 2.31% | -15.61% | |
77 Outperform | ¥235.97B | 11.03 | ― | 2.50% | 1.29% | -4.59% | |
72 Outperform | ¥199.32B | 14.12 | 10.28% | 2.77% | 2.70% | -0.60% | |
67 Neutral | ¥114.94B | 17.07 | ― | 3.77% | -5.08% | 46.70% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |